Bvf Inc 4 D Molecular Therapeutics, Inc. Transaction History
Bvf Inc
- $3.15 Billion
- Q3 2024
A detailed history of Bvf Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 7,382,642 shares of FDMT stock, worth $56 Million. This represents 2.54% of its overall portfolio holdings.
Number of Shares
7,382,642
Previous 3,922,413
88.22%
Holding current value
$56 Million
Previous $82.3 Million
3.07%
% of portfolio
2.54%
Previous 2.52%
Shares
7 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Ra Capital Management, L.P. Boston, MA5.1MShares$38.7 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$37.2 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$33.4 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$31.1 Million1.63% of portfolio
-
Goldman Sachs Group Inc New York, NY3.59MShares$27.3 Million0.01% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $246M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...